Mapping, Structure and Modulation of PPI

被引:35
作者
Martino, Elisa [1 ]
Chiarugi, Sara [1 ,2 ]
Margheriti, Francesco [1 ]
Garau, Gianpiero [2 ]
机构
[1] Scuola Normale Super Pisa, Lab NEST, Pisa, Italy
[2] Ist Italiano Tecnol IIT NEST, BioStruct Lab, Pisa, Italy
来源
FRONTIERS IN CHEMISTRY | 2021年 / 9卷
关键词
PPI in disease1; target structure2; modulation strategies3; protein-protein4; ligand interaction5; PROTEIN-PROTEIN INTERACTIONS; DRUG DISCOVERY; NMR; CELL; NETWORKS; TECHNOLOGIES; SPECTROSCOPY; INHIBITORS; BINDING; SERVER;
D O I
10.3389/fchem.2021.718405
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Because of the key relevance of protein-protein interactions (PPI) in diseases, the modulation of protein-protein complexes is of relevant clinical significance. The successful design of binding compounds modulating PPI requires a detailed knowledge of the involved protein-protein system at molecular level, and investigation of the structural motifs that drive the association of the proteins at the recognition interface. These elements represent hot spots of the protein binding free energy, define the complex lifetime and possible modulation strategies. Here, we review the advanced technologies used to map the PPI involved in human diseases, to investigate the structure-function features of protein complexes, and to discover effective ligands that modulate the PPI for therapeutic intervention.
引用
收藏
页数:8
相关论文
共 64 条
  • [1] Bludau I, 2020, NAT REV MOL CELL BIO, V21, P327, DOI 10.1038/s41580-020-0231-2
  • [2] Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]
  • [3] NMR analysis of protein interactions
    Bonvin, AMJJ
    Boelens, R
    Kaptein, R
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (05) : 501 - 508
  • [4] In-cell NMR for protein-protein interactions (STINT-NMR)
    Burz, David S.
    Dutta, Kaushik
    Cowburn, David
    Shekhtman, Alexander
    [J]. NATURE PROTOCOLS, 2006, 1 (01) : 146 - 152
  • [5] Mapping, modeling, and characterization of protein-protein interactions on a proteomic scale
    Cafarelli, T. M.
    Desbuleux, A.
    Wang, Y.
    Choi, S. G.
    De Ridder, D.
    Vidal, M.
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2017, 44 : 201 - 210
  • [6] A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions
    Chen, Han
    Coseno, Molly
    Ficarro, Scott B.
    Mansueto, My Sam
    Komazin-Meredith, Gloria
    Boissel, Sandrine
    Filman, David J.
    Marto, Jarrod A.
    Hogle, James M.
    Coen, Donald M.
    [J]. ACS INFECTIOUS DISEASES, 2017, 3 (02): : 112 - 118
  • [7] Comprehensive characterization of protein-protein interactions perturbed by disease mutations
    Cheng, Feixiong
    Zhao, Junfei
    Wang, Yang
    Lu, Weiqiang
    Liu, Zehui
    Zhou, Yadi
    Martin, William R.
    Wang, Ruisheng
    Huang, Jin
    Hao, Tong
    Yue, Hong
    Ma, Jing
    Hou, Yuan
    Castrillon, Jessica A.
    Fang, Jiansong
    Lathia, Justin D.
    Keri, Ruth A.
    Lightstone, Felice C.
    Antman, Elliott Marshall
    Rabadan, Raul
    Hill, David E.
    Eng, Charis
    Vidal, Marc
    Loscalzo, Joseph
    [J]. NATURE GENETICS, 2021, 53 (03) : 342 - +
  • [8] Single-particle cryo-EM-How did it get here and where will it go
    Cheng, Yifan
    [J]. SCIENCE, 2018, 361 (6405) : 876 - +
  • [9] Applications of In Silico Methods for Design and Development of Drugs Targeting Protein-Protein Interactions
    Cicaloni, Vittoria
    Trezza, Alfonso
    Pettini, Francesco
    Spiga, Ottavia
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (07) : 534 - 554
  • [10] Motif mediated protein-protein interactions as drug targets
    Corbi-Verge, Carles
    Kim, Philip M.
    [J]. CELL COMMUNICATION AND SIGNALING, 2016, 14